Detalles de la búsqueda
1.
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy >â¯40â¯Gy after systemic treatment.
Strahlenther Onkol
; 194(7): 627-637, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29497791
2.
DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.
Strahlenther Onkol
; 193(4): 315-323, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28116446
3.
Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
Strahlenther Onkol
; 192(1): 1-7, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26403912
4.
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Int J Mol Sci
; 17(2)2016 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26821018
5.
IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Int J Cancer
; 136(5): 1193-201, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24995409
6.
DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily: high local control in early stage (I/II) non-small-cell lung cancer.
Strahlenther Onkol
; 191(3): 256-63, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25245469
7.
Hypofractionated stereotactic radiotherapy of acoustic neuroma: volume changes and hearing results after 89-month median follow-up.
Strahlenther Onkol
; 190(9): 798-805, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24638268
8.
Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR).
Radiother Oncol
; 196: 110294, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653380
9.
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Radiother Oncol
; 185: 109728, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301259
10.
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate.
Cancers (Basel)
; 15(7)2023 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046627
11.
Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
BMC Cancer
; 12: 283, 2012 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22780988
12.
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
Cancers (Basel)
; 14(13)2022 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804997
13.
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Diagnostics (Basel)
; 12(5)2022 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626183
14.
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Cancers (Basel)
; 14(3)2022 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158841
15.
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Breast Cancer
; 29(2): 274-286, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34865205
16.
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.
Curr Oncol
; 28(3): 1835-1846, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34068043
17.
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.
Thorac Cancer
; 12(8): 1162-1170, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33586228
18.
In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO).
Sci Rep
; 11(1): 4590, 2021 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33633130
19.
Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Strahlenther Onkol
; 186(7): 374-81, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20582393
20.
Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review.
Thorac Cancer
; 11(6): 1375-1385, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32323484